164 related articles for article (PubMed ID: 14977838)
1. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival.
Kim GE; Kim YB; Cho NH; Chung HC; Pyo HR; Lee JD; Park TK; Koom WS; Chun M; Suh CO
Clin Cancer Res; 2004 Feb; 10(4):1366-74. PubMed ID: 14977838
[TBL] [Abstract][Full Text] [Related]
2. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
Pyo H; Kim YB; Cho NH; Suh CO; Park TK; Yun YS; Kim GE
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):725-32. PubMed ID: 15936552
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma.
Ranelletti FO; Almadori G; Rocca B; Ferrandina G; Ciabattoni G; Habib A; Galli J; Maggiano N; Gessi M; Lauriola L
Int J Cancer; 2001 Nov; 95(6):343-9. PubMed ID: 11668514
[TBL] [Abstract][Full Text] [Related]
7. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma.
Cho NH; Kim YB; Park TK; Kim GE; Park K; Song KJ
Gynecol Oncol; 2003 Nov; 91(2):346-53. PubMed ID: 14599865
[TBL] [Abstract][Full Text] [Related]
8. High cyclooxygenase-2 expression in cervical adenocarcinomas.
Chen YJ; Wang LS; Wang PH; Lai CR; Yen MS; Ng HT; Yuan CC
Gynecol Oncol; 2003 Mar; 88(3):379-85. PubMed ID: 12648590
[TBL] [Abstract][Full Text] [Related]
9. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Holden J; Davis M; Zempolich K; Murphy KJ; Dodson M
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1213-7. PubMed ID: 11286825
[TBL] [Abstract][Full Text] [Related]
10. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.
Ferrandina G; Lauriola L; Distefano MG; Zannoni GF; Gessi M; Legge F; Maggiano N; Mancuso S; Capelli A; Scambia G; Ranelletti FO
J Clin Oncol; 2002 Feb; 20(4):973-81. PubMed ID: 11844819
[TBL] [Abstract][Full Text] [Related]
11. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study.
Tangjitgamol S; Ramirez PT; Sun CC; See HT; Jhingran A; Kavanagh JJ; Deavers MT
Int J Gynecol Cancer; 2005; 15(4):646-56. PubMed ID: 16014119
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G
Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.
Chen HH; Su WC; Chou CY; Guo HR; Ho SY; Que J; Lee WY
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1093-100. PubMed ID: 16099602
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor.
Itoh S; Matsui K; Furuta I; Takano Y
Oral Oncol; 2003 Dec; 39(8):829-35. PubMed ID: 13679206
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic implications of the epidermal growth factor receptor, cyclooxygenase 2 expression, and human papillomavirus status in squamous cell carcinoma of the uterine cervix in the elderly.
Giordano G; D'Adda T; Dal Bello B; Brigati F; Bersiga A; Campanini N; Berretta R; Rocco A; Merisio C
Int J Gynecol Cancer; 2011 Feb; 21(2):337-48. PubMed ID: 21270615
[TBL] [Abstract][Full Text] [Related]
17. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
Cho EI; Kowalski DP; Sasaki CT; Haffty BG
Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
[TBL] [Abstract][Full Text] [Related]
18. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
19. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
20. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
